Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service provider of cost-effective solutions designed for the proper management of medical waste, used healthcare materials and unused dispensed medications announced today that each month it will donate to the Houston chapter of the American Diabetes Association (ADA) one cent for every pound of used syringes, medical waste and other used healthcare materials the Company processes. “We firmly support and align ourselves with the ADA’s mission to improve the lives of all people affected by diabetes and we both also share concerns as to the personal and environmental dangers resulting from the improper disposal of used syringes, needles and other sharps devices supporting the health and well being of people with diabetes. This program encourages proper treatment while benefitting the ADA in its mission,” commented David P. Tusa, President and CEO of Sharp’s Compliance. J. Ralston Creswell, Senior Executive Director of the ADA Southeast Texas, stated, “In the greater Houston area we have approximately 400,000 people who live with type 1 or type 2 diabetes, and who self-inject insulin or other medications for their health. We take seriously our responsibility to educate our members on safe needle containment and disposal in their homes for the safety of their families, communities as well as themselves. The Penny-a-Pound Program will provide us the additional funding needed to continue educating our members in the importance of proper sharps disposal.” Mr. Tusa concluded, “It is estimated that there are approximately 13.5 million people in the U.S. that legally self-inject medications which generate an estimated 8 billion used syringes, the vast majority of which are improperly handled and end up in our solid waste stream and landfills. Through our revolutionary Waste Conversion Process, all returned syringes are repurposed into a new industrial material, PELLA-DRX, which is used as fuel to generate electricity for thousands of homes, thereby reducing the environmental impact of medical waste.”
About Sharps Compliance Corp.Headquartered in Houston, Texas, Sharps Compliance is a leading full-service provider of solutions for the cost effective management of medical waste, used healthcare materials and unused dispensed medications. Its strategy is to capture a large part of the estimated $3.8 billion untapped market for its solutions by targeting the major agencies that are interrelated with this medical waste stream; including, pharmaceutical manufacturers, home healthcare providers, retail pharmacies and clinics, the U.S. government and the professional market which is comprised of physicians, dentists and veterinary practices. As a fully integrated medical waste management company providing customer solutions and services, the Company’s solid business model, which provides strong margins and significant operating leverage, combined with its early penetration into emerging markets, uniquely positions it for strong future growth. The Company’s flagship product, the Sharps® Recovery System™ is a comprehensive solution for the containment, transportation, treatment and tracking of medical waste and used healthcare materials. The Company’s TakeAway Environmental Return System™ is designed for individual consumers, retail or mail-order pharmacies, communities and facilities including assisted living, long-term care and correction operations to facilitate the proper disposal of unused dispensed medications. The Complete Needle Collection & Disposal System™ is a safe, easy-to-use and cost-effective solution designed for self-injecting consumers and includes the Company’s containment, packaging, return shipping via the U.S. Postal Service, tracking and treatment. The Company has partnered with Daniels Sharpsmart in a joint marketing alliance to serve the entire U.S. medical waste market, offering customers a blended product portfolio to effectively target healthcare customers with multi-site and multi-size locations. The alliance also enables a team effort for cross selling each company’s capabilities where best suited. More information on the Company and its products can be found on its website at: www.sharpsinc.com About ADA The American Diabetes Association is leading the fight to Stop Diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research for the prevention, cure and management diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, their mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish. Safe Harbor Statement The information made available in this press release contains certain forward-looking statements which reflect Sharps Compliance Corp.’s current view of future events and financial performance. Wherever used, the words “estimate”, “expect”, “plan”, “anticipate”, “believe”, “may” and similar expressions identify forward-looking statements. Any such forward-looking statements are subject to risks and uncertainties and the company’s future results of operations could differ materially from historical results or current expectations. Some of these risks include, without limitation, the company’s ability to educate its customers, development of public awareness programs to educate the identified consumer, customer preferences, the Company’s ability to scale the business and manage its growth, the degree of success the Company has at gaining more large customer contracts, managing regulatory compliance and/or other factors that may be described in the company’s annual report on Form 10-K, quarterly reports on Form 10-Q and/or other filings with the Securities and Exchange Commission. Future economic and industry trends that could potentially impact revenues and profitability are difficult to predict. The Company assumes no obligation to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results express or implied therein will not be realized.